Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

The CEO Behind ROC's IPO: How VisionAI Is Redefining Biometric Intelligence

ROC CEO B. Scott Swann joins us live from the NYSE to discuss the company's IPO and how VisionAI is transforming facial recognition for defense and security.

Big Business This Week: Does the private credit crisis have echoes Of 2008?

If you asked anyone in 2007 what a “subprime mortgage” was, they wouldn’t have any idea. So here’s a question for you: Do you know what the private credit

Is Drone Delivery Finally Ready for the Real World?

Matternet founder and CEO Andreas Raptopoulos on the state of drone delivery in the U.S. and what it will take to make aerial delivery a mainstream reality.

Powell Holds Firm: Why the Fed Is Refusing to Cut Rates Right Now

Truist's Head of US Economics Mike Skordeles breaks down the Fed's decision to hold rates steady and what it means for your money and the economy.

$84 Trillion Is Changing Hands: Here's How to Protect Your Legacy

Wells Fargo's Heather Hunt-Ruddy on the Great Wealth Transfer — what families must do now to protect, preserve, and pass on generational wealth.

Inside the Legal Battle Taking Aim at Anthropic

TechCrunch's Rebecca Bellan breaks down the lawsuit against Anthropic and what it could mean for the future of AI development and copyright law.

Load More